Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 03, 2025 Filed Mar 5, 2025 22:27 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 758 $77.75 $58,934.50
Disclosure

SEC source: 0001628280-25-010590 · wk-form4_1741213663.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 344,861

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 758 shares sold at prices ranging from $77.13 to $78.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:27 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 7,317 $76.24 $557,848.08
Disclosure

SEC source: 0001628280-25-010590 · wk-form4_1741213663.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 345,619

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 7,317 shares sold at prices ranging from $75.91 to $76.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:27 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 18,750 $22.76 $426,750.00
Disclosure

SEC source: 0001628280-25-010590 · wk-form4_1741213663.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 352,936

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:39 UTC GiftCommon Stock 481 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 4

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Melvin Sharoky C/F Sophie C. Wink UTMA/FL

Disclosed balance after: 4,764

F3 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:39 UTC GiftCommon Stock 481 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL

Disclosed balance after: 3,481

F2 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:39 UTC GiftCommon Stock 481 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Melvin Sharoky C/F Nolan M. Wink UTMA/FL

Disclosed balance after: 5,180

F1 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:39 UTC GiftCommon Stock 1,443 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,734

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,830 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · derivative · entry 11

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 204,970

Underlying: Common Stock · 6,830 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 18,750 $0.00 Strike: $22.76 $0.00
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · derivative · entry 10

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 18,750 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 300 $81.81 $24,543.00
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 8

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 233,924

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F8 · price: This is the weighted average sales price representing 300 shares sold at prices ranging from $81.69 to $82.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 6,074 $81.07 $492,419.18
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 234,224

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · price: This is the weighted average sales price representing 6,074 shares sold at prices ranging from $80.51 to $81.42 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 456 $80.00 $36,480.00
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 6

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,298

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · price: This is the weighted average sales price representing 456 shares sold at prices ranging from $79.50 to $80.34 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 6,830 $10.85 $74,105.50
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 5

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 754 $81.67 $61,579.18
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 334,186

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · price: This is the weighted average sales price representing 754 shares sold at prices ranging from $81.56 to $81.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 16,743 $81.08 $1,357,522.44
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 334,940

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 16,743 shares sold at prices ranging from $80.50 to $81.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 1,253 $79.95 $100,177.35
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 351,683

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 1,253 shares sold at prices ranging from $79.50 to $80.35 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 18,750 $22.76 $426,750.00
Disclosure

SEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 352,936

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Since the date of the last ownership report for the Reporting Person, he transferred 92,155 shares of Company common stock, employee stock options to purchase 1,064,717 shares of Company common stock, and restricted stock units covering 27,553 shares of Company common stock to his ex-spouse pursuant to a mutually agreed divorce settlement approved by a court that qualifies as a domestic relations order. A domestic relations order is a court order that dictates how assets should be divided between spouses during a divorce, including securities in the Company. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 700 $81.00 $56,700.00
Disclosure

SEC source: 0001628280-25-006804 · wk-form4_1740088339.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,863

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 700 shares sold at prices ranging from $81.00 to $81.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 17,622 $80.28 $1,414,694.16
Disclosure

SEC source: 0001628280-25-006804 · wk-form4_1740088339.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,563

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 17,622 shares sold at prices ranging from $80.00 to $80.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 12, 2025 Filed Feb 13, 2025 22:09 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 5,019 $80.00 $401,520.00
Disclosure

SEC source: 0001628280-25-005465 · wk-form4_1739484553.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,185

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 22:09 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 13,302 $80.00 $1,064,160.00
Disclosure

SEC source: 0001628280-25-005465 · wk-form4_1739484553.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,204

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:45 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 26,141 $79.33 $2,073,765.53
Disclosure

SEC source: 0001628280-25-005166 · wk-form4_1739396737.xml · nonDerivative · entry 3

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,082

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 26,141 shares sold at prices ranging from $78.61 to $79.54 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:45 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 5,781 $78.36 $452,999.16
Disclosure

SEC source: 0001628280-25-005166 · wk-form4_1739396737.xml · nonDerivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 172,223

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 5,781 shares sold at prices ranging from $78.10 to $78.59 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:45 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 11,053 $77.02 $851,302.06
Disclosure

SEC source: 0001628280-25-005166 · wk-form4_1739396737.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,004

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 11,053 shares sold at prices ranging from $76.74 to $77.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:45 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 23,010 $79.33 $1,825,383.30
Disclosure

SEC source: 0001628280-25-005165 · wk-form4_1739396726.xml · nonDerivative · entry 3

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,165

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 23,010 shares sold at prices ranging from $78.61 to $79.54 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:45 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 5,089 $78.36 $398,774.04
Disclosure

SEC source: 0001628280-25-005165 · wk-form4_1739396726.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,175

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 5,089 shares sold at prices ranging from $78.10 to $78.59 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:45 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 9,729 $77.02 $749,327.58
Disclosure

SEC source: 0001628280-25-005165 · wk-form4_1739396726.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,264

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 9,729 shares sold at prices ranging from $76.74 to $77.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 07, 2025 Filed Feb 7, 2025 22:11 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 60 $79.59 $4,775.40
Disclosure

SEC source: 0001628280-25-004465 · wk-form4_1738966304.xml · nonDerivative · entry 3

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,993

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

Read SEC document
February 07, 2025 Filed Feb 7, 2025 22:11 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 100 $79.57 $7,957.00
Disclosure

SEC source: 0001628280-25-004463 · wk-form4_1738966283.xml · nonDerivative · entry 3

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,057

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 100 shares sold at prices ranging from $79.56 to $79.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 07, 2025 Filed Feb 7, 2025 22:11 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 10 $78.91 $789.10
Disclosure

SEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,015

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:11 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 33,055 $80.90 $2,674,149.50
Disclosure

SEC source: 0001628280-25-004465 · wk-form4_1738966304.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,053

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 33,055 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:11 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 23,500 $80.90 $1,901,150.00
Disclosure

SEC source: 0001628280-25-004464 · wk-form4_1738966294.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,878

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 23,500 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:11 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 45,605 $80.90 $3,689,444.50
Disclosure

SEC source: 0001628280-25-004463 · wk-form4_1738966283.xml · nonDerivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,157

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 45,605 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:11 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 79,350 $80.90 $6,419,415.00
Disclosure

SEC source: 0001628280-25-004461 · wk-form4_1738966272.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453,894

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 79,350 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:11 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 7,910 $80.90 $639,919.00
Disclosure

SEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,025

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:10 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 28,390 $80.90 $2,296,751.00
Disclosure

SEC source: 0001628280-25-004459 · wk-form4_1738966251.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,506

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 28,390 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:10 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 20,650 $80.90 $1,670,585.00
Disclosure

SEC source: 0001628280-25-004458 · wk-form4_1738966239.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,610

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 20,650 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:11 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 70,943 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004465 · wk-form4_1738966304.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,108

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:11 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantCommon Stock 47,295 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004464 · wk-form4_1738966294.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,378

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:11 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock 88,680 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004463 · wk-form4_1738966283.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,762

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:11 UTC
Lewis WilliamDirector · Chair and CEO
GrantCommon Stock 153,710 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004461 · wk-form4_1738966272.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 533,244

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:11 UTC
Wise John DraytonChief Commercial Officer
GrantCommon Stock 15,373 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,935

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:10 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock 65,033 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004459 · wk-form4_1738966251.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,896

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:10 UTC
Smith Michael AlexanderChief Legal Officer
GrantCommon Stock 47,295 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004458 · wk-form4_1738966239.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,260

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:44 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,830 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · derivative · entry 13

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 211,800

Underlying: Common Stock · 6,830 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:44 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 18,750 $0.00 Strike: $22.76 $0.00
Disclosure

SEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · derivative · entry 12

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 18,750 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:44 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 2,581 $78.40 $202,350.40
Disclosure

SEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 10

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 233,924

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F8 · price: This is the weighted average sales price representing 2,581 shares sold at prices ranging from $78.26 to $78.75 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:44 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 3,463 $77.95 $269,940.85
Disclosure

SEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 9

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 236,505

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · price: This is the weighted average sales price representing 3,463 shares sold at prices ranging from $77.24 to $78.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:44 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 745 $76.43 $56,940.35
Disclosure

SEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 8

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 239,968

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · price: This is the weighted average sales price representing 745 shares sold at prices ranging from $76.10 to $76.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:44 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 41 $74.86 $3,069.26
Disclosure

SEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,713

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.